Not exact matches
In the last four years, the U.S. - based Human Microbiome
Project used
genomic analysis to identify bacteria, viruses, fungi, archaea, and protozoa in the noses, gums, tonsils, genital tracts, and guts of 242 healthy Americans between the ages of 18 and 40; more than 11,000 samples were taken in all.
These
genomic variations have been revealed by studies in the population and by
analysis of the genomes of colon cancer patients that are available in data bases such as that of the 1000 Genomes
Project Data.
The U.S. - based Human Microbiome
Project used
genomic analysis to I.D. microbes in the noses, gums, tonsils, genital tracts and guts of more than 200 Americans.
Among other initiatives, his group contributes to ENCODE (Encyclopedia of DNA Elements), supported by NIH to define functional
genomic elements; the DOE Systems Biology Knowledgebase (KBase) for data sharing and
analysis; and the internationally funded 1000 Genomes
Project on human genetic variation.
Hadfield and his colleagues are doing large - scale
genomic analyses of different tumor types, as part of the massive Genomics England
project to sequence 100,000 British genomes.
We are using the most powerful and advanced techniques including metabolomics, transcriptomics,
genomics and the
analysis of the gut microbiota to understand what effect, the Mediterranean style diet has on the population of over 65 years old» said prof. Claudio Franceschi,
project coordinator from the University of Bologna, Italy.
We consider the release and maintenance of scientific software an integral part of scientific publishing, and we contribute to the Bioconductor
Project, an open source software collaboration to provide tools for the
analysis and study of high - throughput
genomic data.
In addition to Doñana Biological Station (EBD - CSIC), also taking part in the
project were the National Center for
Genomic Analysis (CNAG - CRG); the Centre for
Genomic Regulation (CRG); the Spanish National Cancer Research Center (CNIO); the Evolutionary Genomics Group of the Hospital del Mar Medical Research Institute (IMIM); the Institute of Evolutionary Biology (IBE, CSIC - UPF); the University Institute of Oncology of Asturias (IUOPA); the Institut de Biotecnologia i de Biomedicina and the Unit of Cell Culture of the Autonomous University of Barcelona (UAB); the Biological Research Center (CIB - CSIC) and the Catalan Institution for Research and Advanced Studies (ICREA).
For example, the BRAIN Initiative supports a series of
projects that are characterizing mammalian brain cell types using single - cell
genomic analysis.
The Cancer, Ageing and Somatic Mutation Programme encompasses three
Projects that respectively cover the
genomics of human cancers; functional
analysis of the cancer genome using a range of in vitro and in vivo model systems; and the characterisation of somatic mutations in development and adult homeostasis in health and disease.
As an example, the ICGC / TCGA Pan-Cancer
Analysis of Whole Genomes (PCAWG)
project, co-led by our group, is leveraging cloud solutions to globally standardize and analyze cancer
genomics data, with the aim of uncovering commonalities and differences between molecular disease mechanisms in disparate cancer entities.
Our main goal in this
project is to use NGS in identification of genetic causes of rare / ultrarare early - onset neurologic diseases, integrating «omics» platforms with systematic approaches to enrich and redefine phenotypic ontology in these conditions, allowing a comprehensive
analysis of
genomic data.
Such
analyses will be based on novel
genomic, transcriptomic and epigenetic datasets generated for all mature blood cell types and their precursors by the EU - funded BLUEPRINT
project.
The
project will also benefit from the RD - Connect Genome - Phenome
Analysis Platform developed at CNAG - CRG; in this case, it will be used to collate existing and newly generated
genomic and phenotypic data.
The goal of this
project is to identify the specific nucleotide sequences and / or single nucleotide polymorphisms that are correlated with expression of virulence and disease via comparative
genomic analysis between B. pseudomallei strains as well as between various bacteriophages harbored within B. pseudomallei.
The Swedish Biodiversity Program aims to target biodiversity of bacteria, viruses, archaea and eukaryotes and combinations thereof to promote large research
projects aiming to uncover and understand
genomic variability in nature by use of massively parallel sequencing and microbial single cell
analysis.
He is currently collaborating with researchers in the lab on various
projects related to HIV and ZIKA, including
analyses regarding
genomics, transcriptomics, and proteomics.
During the pilot phase, the
Project is undertaking a series of planned
analyses that will form the basis of a manuscript, «A global reference for
genomic variation in Plasmodium falciparum», using Pilot Phase data (2,512 samples).
In both
projects the CNAG - CRG has an essential role, carrying out clinical grade sequence
analysis and piloting the development of a clinical -
genomics platform for cancer and rare disease diagnostics for the Catalan Health Service, based on the RD - Connect platform developed at CNAG - CRG in the framework of an EU
project.
Laboratory activities minimally include performing a lab - based patient - oriented research
project applicable to cancer
genomics, with an emphasis on mastering techniques commonly used within a human genetics laboratory, such as PCR, gene sequencing, mutation
analysis, western blots, and functional protein studies.
In both
projects the CNAG - CRG has an essential role, carrying out clinical grade sequence
analysis and piloting the development of a clinical -
genomics platform for cancer and rare disease diagnostics.
The use of this metadata standard by all ongoing and future GSCID sequencing
projects will provide a consistent representation of these data in the BRC resources and other repositories that leverage these data, allowing investigators to identify relevant
genomic sequences and perform comparative
genomics analyses that are both statistically meaningful and biologically relevant.
The most pertinent to this
project is «Dynamic Visualization and Comparative
Analysis of Multiple Collinear
Genomic Data.»
Tags for this Online Resume: DNA and sequencing
analysis, Experince in managing DNA lab, Skilled in managing multiple
projects simultaneously, Experience in quality assurance, Phytobacteriologist / Microbiolgist, Skilled in plant genetics and
genomics
Tags for this Online Resume: Biotechnology, Diagnostic, Pharmaceutical, Marketing, Oncology, Strategy, Brand Planning, Global Marketing, New Product Planning, Pricing, Market Research, Brand Leader, Commercial, Commercialization, Launch, Drug Development, Matrix, Cross Functional, Digital, KOL, Key Opinion Leader, Portfolio, Management, Brand Team, Agency, Diabetes, Cardiovascular, Commercial Strategy, Corporate Affairs, Communications, Hematology, Urology, Neuroscience, phase 2, phase 3, phase II, phase III, Powerpoint, Excel, Word, Part B, Part D, Seattle, Portland, San Francisco, Executive Director, Senior Director, Director, Vice President, Go - To - Market, Value Proposition, Go To Market, Launch Planning, Access, Reimbursement, Payer, Market Development, Market Assessment, Pipeline, In - Line, Brand Management, Coaching, Leadership, Marketing Strategies, Marketing Strategy, Strategic Planning, Autoimmune, Early Stage, Pre-Launch, Pre Launch, Regulatory, Operations, Marketing Plan, Business Plan, Business Development, Market
Analysis, Segmentation, Targeting, Companion Diagnostic, Target Product Profile, Pre-Clinical, Competition, Positoning, Branding, Sales, Budget, Sales Management, Communication Plan, Publication Plan,
Project Management, Genetic,
Genomic, Lifecycle, Long Range, Device, Late Stage, Direct Report, Indirect Report, New Molecular Entities, Competitive, Biopharmaceutical, Medical Device, Non-Promotional, Tactical, Execution, IND, Revenue, Partner, Clinical, Consult, Analytical, Problem Solver, Global, International, Affordable Care Act, Lymphoma, Leukemia, Prostate, Breast, Cancer, OPDP, Promotional, Promotions, Brand, Healthcare, Distribution, Infrastructure, IMS, Priority Review, Experienced, Patient, Consumer